Teza Capital Management LLC reduced its holdings in Centene Co. (NYSE:CNC - Free Report) by 26.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 28,429 shares of the company's stock after selling 10,184 shares during the quarter. Teza Capital Management LLC's holdings in Centene were worth $1,722,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Stratos Wealth Partners LTD. increased its position in Centene by 4.1% during the 4th quarter. Stratos Wealth Partners LTD. now owns 4,094 shares of the company's stock valued at $248,000 after purchasing an additional 163 shares during the period. Capital Advisors Ltd. LLC increased its position in shares of Centene by 75.3% during the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock valued at $25,000 after buying an additional 177 shares during the period. Private Trust Co. NA raised its stake in Centene by 23.7% in the fourth quarter. Private Trust Co. NA now owns 956 shares of the company's stock worth $58,000 after buying an additional 183 shares in the last quarter. Howard Capital Management Inc. boosted its position in Centene by 5.4% during the 4th quarter. Howard Capital Management Inc. now owns 3,591 shares of the company's stock valued at $218,000 after acquiring an additional 184 shares in the last quarter. Finally, Intellectus Partners LLC grew its holdings in shares of Centene by 2.8% during the 4th quarter. Intellectus Partners LLC now owns 7,224 shares of the company's stock worth $438,000 after acquiring an additional 200 shares during the period. Institutional investors own 93.63% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on the company. Robert W. Baird dropped their price target on Centene from $71.00 to $69.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 15th. Guggenheim restated a "neutral" rating on shares of Centene in a report on Tuesday, April 29th. Jefferies Financial Group lowered their price target on shares of Centene from $64.00 to $61.00 and set a "hold" rating for the company in a research report on Tuesday, April 29th. Argus cut shares of Centene from a "buy" rating to a "hold" rating in a report on Thursday, February 6th. Finally, Wells Fargo & Company lowered their target price on shares of Centene from $76.00 to $72.00 and set an "overweight" rating for the company in a report on Friday, February 14th. Seven research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, Centene presently has a consensus rating of "Moderate Buy" and a consensus target price of $79.77.
Read Our Latest Report on CNC
Centene Stock Down 3.4%
Shares of Centene stock traded down $1.95 on Friday, reaching $56.12. The company's stock had a trading volume of 2,482,392 shares, compared to its average volume of 4,872,303. Centene Co. has a 52 week low of $55.03 and a 52 week high of $80.59. The firm's fifty day simple moving average is $60.83 and its two-hundred day simple moving average is $60.40. The company has a quick ratio of 1.10, a current ratio of 1.11 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $27.93 billion, a price-to-earnings ratio of 8.97, a P/E/G ratio of 0.80 and a beta of 0.48.
Centene (NYSE:CNC - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $2.90 earnings per share for the quarter, topping analysts' consensus estimates of $2.52 by $0.38. Centene had a return on equity of 13.85% and a net margin of 2.03%. The business had revenue of $46.62 billion during the quarter, compared to analyst estimates of $43.16 billion. During the same quarter in the previous year, the firm earned $2.26 EPS. Centene's revenue was up 15.4% on a year-over-year basis. Equities analysts anticipate that Centene Co. will post 6.86 earnings per share for the current year.
About Centene
(
Free Report)
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Stories
Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
